203 related articles for article (PubMed ID: 21719059)
1. Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.
Arafat H; Lazar M; Salem K; Chipitsyna G; Gong Q; Pan TC; Zhang RZ; Yeo CJ; Chu ML
Surgery; 2011 Aug; 150(2):306-15. PubMed ID: 21719059
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.
Kang CY; Wang J; Axell-House D; Soni P; Chu ML; Chipitsyna G; Sarosiek K; Sendecki J; Hyslop T; Al-Zoubi M; Yeo CJ; Arafat HA
J Gastrointest Surg; 2014 Jan; 18(1):7-15. PubMed ID: 24002763
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression signatures in intraductal papillary mucinous neoplasm of the pancreas.
Lubezky N; Loewenstein S; Ben-Haim M; Brazowski E; Marmor S; Pasmanik-Chor M; Oron-Karni V; Rechavi G; Klausner JM; Lahat G
Surgery; 2013 May; 153(5):663-72. PubMed ID: 23305591
[TBL] [Abstract][Full Text] [Related]
5. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin sulfate proteoglycan CSPG4 as a novel hypoxia-sensitive marker in pancreatic tumors.
Keleg S; Titov A; Heller A; Giese T; Tjaden C; Ahmad SS; Gaida MM; Bauer AS; Werner J; Giese NA
PLoS One; 2014; 9(6):e100178. PubMed ID: 24932730
[TBL] [Abstract][Full Text] [Related]
7. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
[TBL] [Abstract][Full Text] [Related]
8. Adipose tissue collagen VI in obesity.
Pasarica M; Gowronska-Kozak B; Burk D; Remedios I; Hymel D; Gimble J; Ravussin E; Bray GA; Smith SR
J Clin Endocrinol Metab; 2009 Dec; 94(12):5155-62. PubMed ID: 19837927
[TBL] [Abstract][Full Text] [Related]
9. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer.
Jbara A; Lin KT; Stossel C; Siegfried Z; Shqerat H; Amar-Schwartz A; Elyada E; Mogilevsky M; Raitses-Gurevich M; Johnson JL; Yaron TM; Ovadia O; Jang GH; Danan-Gotthold M; Cantley LC; Levanon EY; Gallinger S; Krainer AR; Golan T; Karni R
Nature; 2023 May; 617(7959):147-153. PubMed ID: 36949200
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.
Masugi Y; Yamazaki K; Emoto K; Effendi K; Tsujikawa H; Kitago M; Itano O; Kitagawa Y; Sakamoto M
Lab Invest; 2015 Mar; 95(3):308-19. PubMed ID: 25599535
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.
Lian H; Wang A; Shen Y; Wang Q; Zhou Z; Zhang R; Li K; Liu C; Jia H
BMC Gastroenterol; 2020 Jun; 20(1):171. PubMed ID: 32503434
[TBL] [Abstract][Full Text] [Related]
12. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
[TBL] [Abstract][Full Text] [Related]
13. A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.
Pan TC; Zhang RZ; Arita M; Bogdanovich S; Adams SM; Gara SK; Wagener R; Khurana TS; Birk DE; Chu ML
J Biol Chem; 2014 Apr; 289(15):10293-10307. PubMed ID: 24563484
[TBL] [Abstract][Full Text] [Related]
14. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
15. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
16. Different expression of transforming growth factor beta 1 in pancreatic ductal adenocarcinoma and cystic neoplasms.
Van Laethem JL; Resibois A; Rickaert F; Devière J; Gelin M; Cremer M; Robberecht P
Pancreas; 1997 Jul; 15(1):41-7. PubMed ID: 9211491
[TBL] [Abstract][Full Text] [Related]
17. The long non-coding RNA DKFZp434J0226 regulates the alternative splicing process through phosphorylation of SF3B6 in PDAC.
Li J; Tong H; Li D; Jiang Q; Zhang Y; Tang W; Jin D; Chen S; Qin X; Zhang S; Xue R
Mol Med; 2021 Aug; 27(1):95. PubMed ID: 34470609
[TBL] [Abstract][Full Text] [Related]
18. Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Satoh K; Hamada S; Kanno A; Hirota M; Umino J; Ito H; Masamune A; Egawa S; Unno M; Shimosegawa T
J Gastroenterol; 2010 Jul; 45(7):763-70. PubMed ID: 20107842
[TBL] [Abstract][Full Text] [Related]
19. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma.
Berchtold S; Grünwald B; Krüger A; Reithmeier A; Hähl T; Cheng T; Feuchtinger A; Born D; Erkan M; Kleeff J; Esposito I
Cancer Lett; 2015 Jan; 356(2 Pt B):721-32. PubMed ID: 25449434
[TBL] [Abstract][Full Text] [Related]
20. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
